Alten, Rieke
Mariette, Xavier
Flipo, René-Marc
Caporali, Roberto
Buch, Maya H.
Patel, Yusuf
Marsal, Sara
SanmartĂ, Raimon
Nurmohamed, Michael T.
Griffiths, Hedley
Peichl, Peter
Bannert, Bettina
Chartier, Melanie
Connolly, Sean E.
Lozenski, Karissa
Rauch, Christiane
Funding for this research was provided by:
Bristol Myers Squibb
Article History
Received: 19 November 2021
Revised: 1 April 2022
Accepted: 9 April 2022
First Online: 10 May 2022
Declarations
:
: CR, MC, KL, and SEC are employees and shareholders of Bristol Myers Squibb. BB, YP, and PP have no competing interests. SMB declares consulting/grant/research support/speaker fees from AbbVie, Bristol Myers Squibb, Gilead/Galapagos, Janssen, MSD, Novartis, Pfizer, Roche, Sandoz, Sanofi, and UCB. MHB declares consulting/grant/research support from AbbVie, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, EMD Serono, Pfizer, Roche, Sanofi, and UCB. RC declares consulting and speaker fees from AbbVie, Amgen, Bristol Myers Squibb, Celltrion, Fresenius Kabi, Gilead/Galapagos, Eli Lilly, MSD, Pfizer, Roche, Sanofi, and UCB. R-MF declares consulting and speaker fees from AbbVie, Bristol Myers Squibb, Eli Lilly, MSD, Pfizer, Roche-Chugai, and Sanofi. HG declares consulting/research support/speaker fees from AbbVie, Gilead, Pfizer, and Roche. XM declares honoraria from Bristol Myers Squibb, Galapagos, Gilead, GSK, Janssen, Novartis, Pfizer, and UCB<i>.</i> MN declares consulting/grant/research support/speaker fees from AbbVie, Bristol Myers Squibb, Celgene, Celltrion, Eli Lilly, Galapagos, Janssen, MSD, Mundipharma, Novartis, Pfizer, Roche, and Sanofi. RS declares consulting/grant support from AbbVie, Bristol Myers Squibb, Fresenius, Gebro Pharma, Gilead/Galapagos, Eli Lilly, Pfizer, Roche, Sandoz, and Sanofi. RA declares speaker fees from AbbVie, Amgen, Bristol Myers Squibb, Celltrion, Galapagos, Gilead, Eli Lilly, Novartis, Pfizer, and Roche. Consulting fees from Celltrion, Galapagos, Gilead, Eli Lilly, and Novartis. Research support from Bristol Myers Squibb, Galapagos, Gilead, Novartis, and Pfizer.